CXCL8 and pancreatic neoplasm: Our recent study revealed that CAFs trigger oxaliplatin resistance in pancreatic cancer via IL-8 activation, leading to increased lncRNA UPK1A-AS1 and enhanced NHEJ DNA repair, underscoring ncRNAs vital role in TME-driven platinum resistance [15].